Experience With Antibody-Based Therapies for COVID-19 for Immunocompromised Patients [0.03%]
免疫缺陷患者的COVID-19抗体治疗经验
Margaret McCort,Helen Tsai,Grace Minamoto et al.
Margaret McCort et al.
Facial Nodules and Rib Fracture: An Unusual Presentation of Disseminated Histoplasmosis in a Kidney Transplant Recipient [0.03%]
面部结节和肋骨骨折：一名肾移植受者的组织胞浆菌病的不寻常表现形式
Elizabeth Yasmine Wardoyo,Rajesh Kumar,Hemlata Jangir
Elizabeth Yasmine Wardoyo
Old Pathogens-New Patient Types: Infections in a CAR T-Cell Recipient. Could It Get Any More Complicated? [0.03%]
旧病原新宿主：CAR-T细胞受者继发感染的临床挑战
Monica Melchio,Joshua A Hill,Maunank Shah et al.
Monica Melchio et al.
The case discussed involves a 41-year-old Italian man who was a candidate for chimeric antigen receptor T-cell therapy (CAR-T) for mediastinal diffuse large B-cell lymphoma. His CAR-T treatment was postponed several times due to prolonged r...
Risk Stratification for Seasonal Coronavirus Infections in HCT Recipients: Advances and Challenges [0.03%]
造血干细胞移植受者季节性冠状病毒感染的风险分层：进展与挑战
Chikara Ogimi,Alpana Waghmare
Chikara Ogimi
Burden of Seasonal Human Coronavirus Infections in Hematopoietic Cell Transplant Recipients [0.03%]
造血细胞移植受者季节性人类冠状病毒感染的疾病负担
Fareed Khawaja,Terri Lynn Shigle,Layale Yaghi et al.
Fareed Khawaja et al.
Background: Community respiratory viruses, such as seasonal human coronavirus (HCoV), commonly infect hematopoietic cell transplant (HCT) recipients. Recognizing the risk factors and outcomes of HCoV infections in HCT rec...
Mortality Associated With Cytomegalovirus Reactivation After Umbilical Cord Blood HCT [0.03%]
脐带血造血干细胞移植后巨细胞病毒再活化相关的死亡率分析
Julian Lindsay,Danniel Zamora
Julian Lindsay
Adenovirus Burden in Allogeneic Hematopoietic Stem Cell Transplantation: Monitoring Versus Symptoms-Based Testing-A Cost-Effectiveness Analysis [0.03%]
同种异体造血干细胞移植中的腺病毒负荷：基于监测的检测与基于症状的检测的成本效益分析
Estela Giménez,José Luis Piñana,Eliseo Albert et al.
Estela Giménez et al.
Background: Adenovirus infection (AdVi) causes significant morbidity and mortality in allogeneic hematopoietic stem cell transplantation (allo-HCT) recipients. ...
Trends over Time in Practice and Outcomes of Lung Transplantation in Recipients with Human Immunodeficiency Virus [0.03%]
人免疫缺陷病毒感染者肺移植术实践及预后的变迁趋势分析
Zeba Nauroz,Jessica M Ruck,Pali Shah et al.
Zeba Nauroz et al.
Background: People with human immunodeficiency virus (HIV) are at an increased risk for end-stage lung disease, for which lung transplantation (LT) may be necessary. ...
Associations of Nucleoside Diphosphate-Linked Moiety X-Type Motif 15 Variants With Neutropenia During Antiviral Therapy for Cytomegalovirus Disease in Pediatric Liver Transplant Recipients [0.03%]
核苷二磷酸连接物X型模体15多态性与肝移植受者巨细胞病毒感染抗病毒治疗期间中性粒细胞减少的相关性研究
Ken-Ichi Iwata,Yuka Torii,Yuto Fukuda et al.
Ken-Ichi Iwata et al.
Background: Cytomegalovirus (CMV) infection in pediatric liver transplant recipients is a major concern. Ganciclovir (GCV) and valganciclovir (VGCV) are the first-line treatment agents; however, neutropenia is a common ad...